Relationship between ANCA and disease activity in small vessel vasculitis patients with anti-MPO ANCA

Nephrology Dialysis Transplantation

Volumn 14, Issue 7, 1999, Pages 1667-1672

  Ara, Jordi ^a   Mirapeix, Eduardo ^a   Rodriguez, Rosa ^a   Saurina, Anna ^a   Darnell, Alejandro ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

ANCA; Clinical evolution; Vasculitis

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SEROCONVERSION; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; VASCULITIS;

EID: 0033067456     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.7.1667     Document Type: Article

References (30)

1. Kallenberg CG, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15
2. Mirapeix E. ANCA: Vasculitis and glomerulonephritis. Medicine 1994; 61: 55-64
3. Woude van der FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es et al. Autoantibodies againsts neutrophils and monocytes. Tool for diagnosis and marker disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425
4. Gross WL, Lüdemann G, Kiefer G, Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis (letter). Lancet 1986; 1: 806
5. Lüdemann G, Gross WL. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol 1987; 69: 350-354
6. Nölle B, Specks U, Lüdemann J, Rohrbach M, DeRemee R, Gross W. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989; 111:28-40
7. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651 1657
8. Goldschmeding R, van der Schoot CE, Bokkel Huinink D ten et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989; 84: 1577 1587
9. Cohen Tervaert JW, Goldschmeding R, Elema JD, von dem Borne AE, Kallerberg CG. Antimyeloperoxidase antibodies in Churg-Strauss syndrome. Thorax 1991; 46: 70-71
10. Gaskin G, Ryan JJ, Rees AJ, Pusey CD. Anti-myeloperoxidase antibodies in vasculitis: relationship to ANCA and clinical diagnosis. APMIS 1990; 98 [Suppl 19]: 33
11. Bosch X, Mirapeix E, Font J et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991; 36: 107-113
12. Peter HH, Metzger D, Rump A, Rother E. ANCA in diseases other than systemic vasculitis. Clin Exp Immunol 1993; 93 [Suppl 1]:12-14
13. Cohen Tervaert JW, Huitema MG, Hené RJ, Sluiter TH, Hem van der GK, Kallerberg CG. Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cyloplasmic antibody titre. Lancet 1989; 336: 709-711
14. Jayne D, Heaton A, Brownlee A, Evans DB, Lockwood CM. Sequential antineutrophil cytoplasm antibody titres in management of systemic vasculitis. Nephrol Dial Transplant 1990; 5: 309-310
15. Gaskin CO, Savage JJ, Ryan S, Jones AJ, Rees C, Lockwood CM, Pusey CD. Anti-neutrophil cytoplasmic antibodies and disease activity during long term follow up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991; 6: 689-694
16. Cohen Tervaert JW, Van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461-2465
17. De Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD. Relationship between disease activity and ANCA concentration in long term management of systemic vasculitis. Am J Kidney Dis 1995; 25: 380-389
18. Petterson E, Heigl Z. Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 1992; 37: 219-228
19. Kerr GS, Thomas A, Fleisher CW, Hallahan RL, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-371
20. Rao JK, Weinberger M, Oddone E, Allen N, Landsman P, Freusse J. The role of c-ANCA testing in the diagnosis of Wegener's granulomatosis. Am Intern Med 1995; 123: 925-932
21. Jeannette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
22. Jayne DRW, Rasmussen N, for the European Community Systemic Study Group (ECSYSVASTRIAL). Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European community systemic vasculitis clinical trials study group. Mayo Clin Proc 1997; 72: 737-747
23. Bacon A, Moots RJ, Exley A, Luqmani R, Rasmussen N. Vital assessment of vasculitis. Clin Exp Rheumatol 1995; 13: 275-278
24. Wiik A, Rasmussen N, Weislander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: Van Verooig WJ et al., eds. Manual of Biological Markers of Disease. Kluwer Academic Publishers, Dordrecht: 1993; 1-14
25. Balow JE. Renal vasculitis. Kidney Int 1985; 27: 954-964
26. Hind CRK, Winearls CG, Loockwood CM, Rees AJ, Pepys MB. Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration. Clin Nephrol 1984; 21: 341-345
27. Hind CRK, Savage CO, Winearls CG, Pepys MB. Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration. Br Med J 1984; 288: 1027-1030
28. Ara J, Mirapeix E, Pascual J, Rodriguez R, Darnell A. Valor de los ANCA en el diagnóstico y seguimiento de las vasculitis de pequeño vaso. Nefrologia 1997; 17 [Suppl 2]: 19 (abstract)
29. Mulder AHL, Stegeman CA, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995; 101: 227-232
30. Falk RJ, Terrell RS, Charles LA, Jennette JC. ANCA induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-4119